Qingdao Baheal Medical Inc. (known as “Baheal Medical”, Stock Code: 301015) was founded in 2005. Serving as an innovation brands commercialization platform, Baheal Medical focuses on the development, manufacturing and commercialization of medical innovations, and effectively optimizing the medical practices through technological innovation. 

Through our core technical capabilities in modern traditional Chinese medicine (TCM) and advanced controlled-release formulations, Baheal Medical has established a sophisticated R&D and production system for both TCM and chemical medicines. We have successfully launched a variety of innovative products with proprietary intellectual property rights, and consistently drive forward technological development and production for upstream medical innovations.

Leveraging our well-established commercialization capabilities and extensive nationwide sales and marketing network, Baheal Medical accelerates the adoption of high-quality medical and health products in clinical practices. We have established a comprehensive product matrix covering bone health, organ fibrosis and brain metastases. Baheal Medical also has incubated and commercialized multiple category-leading brands, committed to providing better medical and health products and services to the whole society.